Status
ACTIVE
Global HQ
Athens, Greece
Countries of investment
- Greece
- Spain
- Portugal
- Italy
- France
- Germany
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czechia
- Denmark
- Estonia
- Finland
- Hungary
- Iceland
- Ireland
- Latvia
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Romania
- Slovakia
- Slovenia
- Sweden
- Switzerland
- United Kingdom
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- Women's Health
- Femtech
- Digital Health
- Biotech
- Diagnostics
- Therapeutics
- Medical Devices
- Artificial Intelligence
- Longevity
- Mental Health
About
WHIF is an Athens-based venture capital fund focused on backing women's health innovation originating in Southern Europe and scaling globally. Their focus spans femtech, diagnostics, therapeutics, digital health, and AI applied to female-specific conditions across Greece, Spain, Portugal, Italy, France, and the wider European Union. Founded by Areti Kalogerogianni and pre-launched in 2025, the firm supports women's health founders from pre-seed through Series A.
WHIF is an Athens-based venture capital fund focused on backing women's health innovation originating in Southern Europe and scaling globally. Their focus spans femtech, diagnostics, therapeutics, digital health, and AI applied to female-specific conditions across Greece, Spain, Portugal, Italy, France, and the wider European Union. Founded by Areti Kalogerogianni and pre-launched in 2025, the firm supports women's health founders from pre-seed through Series A.
Investment Thesis
WHIF is a pre-seed to Series A venture capital fund deploying a €50M vehicle exclusively across women's health, femtech, biotech, digital health, and AI-enabled care. They invest in evidence-based solutions spanning the full female lifespan, from reproductive care and pregnancy through menopause, chronic conditions, mental health, and longevity. The firm differentiates itself as Europe's first fund dedicated solely to women's health, with a Southern Europe sourcing advantage built on regional scientific talent and untapped markets.
Manager's Experience
Founded in 2023 by Nora Blum (Founder & CEO of Selfapy, digital mental health platform) and Sabine Anzenhofer (Managing Partner). European women's health-focused fund investing across femtech, reproductive health, and hormonal health. Team combines operator experience from digital health with venture capital investment expertise. Based in Berlin with pan-European mandate.
Team
Areti Kalogerogianni-Founder & Managing Partner